Mycetoma management and clinical outcomes: the Mycetoma Research Center experience
Transactions of The Royal Society of Tropical Medicine and Hygiene · 03.01.2023 · 117 (1) · 12-21
DOI: 10.1093/trstmh/trac069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, online erschienen am 28.07.2022. Verfasst von Esraa Abdelgadir Musa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Program, Faculty of Pharmacy, University of Khartoum, Khartoum 11115, Sudan. Hauptthemen laut MEDLINE: Mycetoma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background
Mycetoma is a chronic granulomatous inflammatory disease that affects the cutaneous and subcutaneous tissues, leading to gruesome complications if not treated early. As a neglected disease, it has received scant attention in developing curable drugs. Mycetoma treatment is still based on expert opinions in the absence of guidelines.
Methods
This descriptive, cross-sectional, hospital-based study aimed to determine and assess the disease treatment outcomes observed at Mycetoma Research Center, Sudan.
Results
In this study, 75% of patients had eumycetoma, all of whom were treated with itraconazole and 37.4% underwent surgical excision, while 25% of the patients had actinomycetoma, 99.2% of whom were treated with a combination of cotrimoxazole and amoxicillin-clavulanate. The cure rate was 12.7% and 14.3% for patients with eumycetoma and actinomycetoma, respectively. Only 6.1% of eumycetoma patients underwent amputation. Remarkably, no patient with actinomycetoma underwent an amputation. Small lesions (OR=10.09, p<0.001) and good follow-up (OR=6.81, p=0.002) were positive predictors of complete cure. In terms of amputation, history of surgical recurrence at presentation (OR=3.67, p=0.020) and presence of grains (OR=7.13, p=0.012) were positive predictors, whereas small lesions were negative predictors (OR=0.06, p=0.009).
Conclusions
Treatment of mycetoma was suboptimal, with a low cure rate despite a long treatment duration. Complete cure has a significant association with small lesions and good follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacy Program, Faculty of Pharmacy, University of Khartoum, Khartoum 11115, Sudan.
- Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum 11115, Sudan.
- Mycetoma Research Center, University of Khartoum, Khartoum 11115, Sudan.
Zitieren
APA
Musa, E. A., Abdoon, I. H., Bakhiet, S. M., Osman, B., Abdalla, S. A., & Fahal, A. H. (2023). Mycetoma management and clinical outcomes: the Mycetoma Research Center experience. Transactions of The Royal Society of Tropical Medicine and Hygiene, 117(1), 12-21. https://doi.org/10.1093/trstmh/trac069
Vancouver
Musa EA, Abdoon IH, Bakhiet SM, Osman B, Abdalla SA, Fahal AH. Mycetoma management and clinical outcomes: the Mycetoma Research Center experience. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2023;117(1):12-21. doi:10.1093/trstmh/trac069
BibTeX
@article{Musa2023,
author = {Musa, Esraa Abdelgadir and Abdoon, Iman Hassan and Bakhiet, Sahar Mubarak and Osman, Bashier and Abdalla, Safa A and Fahal, Ahmed Hassan},
title = {Mycetoma management and clinical outcomes: the Mycetoma Research Center experience},
journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
year = {2023},
volume = {117},
number = {1},
pages = {12--21},
doi = {10.1093/trstmh/trac069}
}
EUVIMED